Author Index:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Abonour, R.
(Nursing) Germ Cell Carcinoma
Aljurf, M. D.
(WC) CIBMTR Working Committee #10: International Studies
Alyea, E. P. III
Allogeneic Transplantation in CLL: Moving Forward Toward Cure?
Ambinder, R.
Practical Considerations in Auto and Allo Transplantation, Possible Strategies for Optimizing Donor Selection
BMT Tandem Luncheon Symposium: HCT in HIV-1 Infected Patients
Anasetti, C.
Mismatched Unrelated Donor Transplantation
2:45PM-3:00PM BMT CTN 0201 Peripheral Blood vs Bone Marrow
Appelbaum, F. R.
ATG in HCT - The Debate
Meet-the-Professor Session 1: How I Write Papers for Publication
BMT Tandem Breakfast Symposium: ATG in HCT
Apperley, J. F.
Allogeneic Transplantation in CML During the Era of Targeted Therapy
Artz, A.
Beyond Feasibility: Allogeneic Transplant for Older Adults
Aging and Transplant in the Elderly
Asgharzadeh, S.
Minimal Residual Disease and Clinical Translation of Genomic Discoveries
Atkins, H.
Canadian Experience with Transplantation for Multiple Sclerosis
Atsuta, Y.
(WC) CIBMTR Working Committee #10: International Studies
Aversa, F.
Haploidentical Related Donor Transplantation
Ayas, M.
(WC) CIBMTR Working Committee #19: Non-Malignant Marrow Disorders

B

Bacher, U.
Methods for Monitoring Minimal Residual Pre- and Post-Allogeneic HCT in Patients with Myeloid Malignancies
Bacigalupo, A.
The Case for ATG
Changes in Stem Cell Transplants: Where Are We Going?
Mortimer M. Bortin Lecture - "Changes in Stem Cell Transplants: Where Are We Going?"
Baekgaard Larsen, H.
(CRP/DM) Mentors' Wine & Cheese Reception
(Nursing) Transplant Nursing Oral Abstracts - Session 1
Baird, K.
Sclerotic Chronic GVHD: Treatments and Challenges in Clinical Trial Research
Baker, K. S.
Morbidity and Mortality Related to New Malignancies and Proposed Screening and Risk-Reduction Strategies
Ball, L. M.
MSCs for the Treatment of cGVHD
Barowski, K.
Protocol Dissection and Adherence
(BMTCTN) Training a New BMT CTN Clinic/Data Coordinator
Bartoo, G.
Outpatient Stem Cell Transplant Clinic (Bartoo)
Batterson, L.
A DEDICATED TRANSPLANT INFORMATICS TEAM ENHANCES QUALITY, SAFETY, AND COMPLIANCE OUTCOMES
Baute, J.
(Nursing) Germ Cell Carcinoma
Beattie, S.
(Nursing) Family Caregiving Issues
Bellarjeau, M.
(Nursing) Hot Topics in HSCT Nursing
Bellman, D.
What Do I Do with All of Those Pesky "Other Specify" Fields?
Bhatia, S.
Pathogenesis of Post-HCT Malignancies
(ADMIN) The Prevalence of Long-Term Complications and Secondary Cancer Among Bone Marrow Transplant Recipients
Oral Abstracts-Session K - Late Effects/Quality of Life & Histocompatibility
New Malignancies after HCT
Bishop, M. R.
Strategies for the Prevention of Relapse in Adult Patients with Myeloid Malignancy Undergoing Allogeneic HCT
Monitoring and Prevention of Relapse after Allogeneic HCT for Myeloid Malignancies
(WC) CIBMTR Working Committee #02: Solid Tumors
Blankson, J.
Understanding HIV-1 Infection, HIV-1 Reservoirs and Aspects of Antiretroviral Therapy and Immune Control
Blazar, B. R.
T Cell: B Cell Cooperativity in Murine Chronic GVHD
Bloomquist, J.
Cord Blood Outcomes Data - What Happens after it is Submitted
Boeckh, M. J.
(WC) CIBMTR Working Committee #14: Infection and Immune Reconstitution
Bollard, C. M.
Diagnosis and Management of EBV Reactivation and PTLD
Borrello, I.
Adoptive Immune Strategies Targeting Myeloma Stem Cells
Brown, W.
(PHARM) Stem Cell Transplantation in Infants
Brunner, J.
Auto Rescue and Post-HCT Therapy Planned and Unplanned
(CRP/DM) Lymphoma Reporting
Brunstein, C. G.
Umbilical Cord Blood Transplantation
Cord, Haplo and MMURD
Oral Abstracts-Session J - Stem Cell Biology & Immune Reconstitution
Bubalo, J.
(PHARM) Engraftment Syndrome
Bunjes, D. W.
(WC) CIBMTR Working Committee #16: Acute Leukemia
Burlingham, W. J.
Impact of T cell Activation and Regulatory T cells in Tolerance After Renal Transplantation
Byrd, J. C.
Update on Biology and Novel Therapies of CLL Impacting Allogeneic Transplantation
BMT Tandem Breakfast Symposium: HCT/CT for CLL/CML

C

Cairo, M. S.
(WC) CIBMTR Working Committee #13: Cellular Therapy
Calderwood, M.
(Nursing) Transplant Nursing Oral Abstracts - Session 1
Carpenter, P. A.
Prevention and Management of Post-Transplant Relapse in AML
1:45PM-2:15PM BMT CTN 0801 Chronic GVHD Treatment
(APP) Management of Relapse Post Transplant
Meet-the-Professor Session 4: How I Manage Chronic GVHD
(WC) CIBMTR Working Committee #04: Pediatric Cancer
Carter, S. L.
(BMTCTN) BMT CTN Q&A
Carver, A.
(PHARM) Stem Cell Transplantation in Infants
Champlin, R. E.
(WC) CIBMTR Working Committee #06: Graft Sources and Manipulation
Chao, N. J.
Lessons Learned from Chernobyl to Fukushima
Chapman, M.
Next Generation Sequencing for Understanding Hematologic Malignancies
Chell, J.
Addressing the Need: Transplant Capacity in 2020
(ADMIN) Access to Allogeneic Transplantation: System Capacity Initiative 2020 Update
Christianson, D.
(CRP/DM) CIBMTR Audits
Chute, J.
Radiation Disaster Planning at the National Level
Coles, T.
(BMTCTN) Coordinator Game
Collins, M.
(CRP/DM) FormsNet/AGNIS
Colvin, K.
(Nursing) Transplant Nursing Oral Abstracts - Session 2
Confer, D. L.
The Radiation Injury Treatment Network
9:30AM-9:45AM Cord Blood Licensing
9:45AM-10:00AM Estimating HLA Match Rates
NMDP: Radiation Disasters - Role of the BMT Team
Cooke, K. R.
(WC) CIBMTR Working Committee #05: Regimen-Related Toxicity and Supportive Care
Cooke, L.
(ADMIN) Yeah, I Get to Go Home, Now What? Addressing the Unique Needs of Bone Marrow Transplant Patients Post Transplant
Cortes, J.
(WC) CIBMTR Working Committee #08: Chronic Leukemia
Couriel, D. R.
Chronic GVHD: The Clinical Perspective
Oral Abstracts-Session L - Allogeneic
Understanding Chronic GVHD from Different Angles
Cowan, M. J.
Novel Murine Models for Overcoming Barriers to Engraftment and Opening Marrow Niches
Crann, M.
Reporting Adverse Events for BMT CTN Studies
Cutler, C.
Pre-clinical Pathophysiology: A Guide to New Strategies
(Nursing) Haplo-Identical/UCB Expansion: Opening Up Transplant to the Masses
(WC) CIBMTR Working Committee #18: Graft-Versus-Host-Disease

D

Daley, G. Q.
Customized Stem Cells for Research and Therapy
Davies, S. M.
Stem Cell Transplantation in AML
(APP) Fanconi Anemia
BMT Tandem Meetings Best Abstracts
Welcome to the 2012 BMT Tandem Meetings
de Lima, M.
Clinical Utility of Hypomethylating Agents Post-HCT
(Nursing) Luncheon Symposium: Tailoring Reduced-Intensity Conditioning: Applying Emerging Evidence to Clinical Practice
(PHARM) Luncheon Symposium: Tailoring Reduced-Intensity Conditioning: Applying Emerging Evidence to Clinical Practice
(APP) Luncheon Symposium: Tailoring Reduced-Intensity Conditioning: Applying Emerging Evidence to Clinical Practice
Critical Decisions: Pretransplant Conditioning
Critical Decisions: Pretransplant Conditioning
Critical Decisions: Pretransplant Conditioning
Deeg, H. J.
(WC) CIBMTR Working Committee #19: Non-Malignant Marrow Disorders
Devine, S. M.
GVHD Prevention Thru T cell Depletion: What Have We Learned?
(ADMIN) Cost Savings Measures through Collaboration
Oral Abstracts-Session B - Autologous Transplantation
(WC) CIBMTR Working Committee #16: Acute Leukemia
DiPersio, J. F.
(PHARM) My Patient's Graft Failed: What Now?
(WC) CIBMTR Working Committee #16: Acute Leukemia
Dispenzieri, A.
(WC) CIBMTR Working Committee #15: Plasma Cell Disorders
Drexler, R. J.
(CRP/DM) RCI-BMT - More Than Just Another Acronym
DuBois, L.
Outpatient Stem Cell Transplant Clinic (DuBois)
Duncan, C.
(WC) CIBMTR Working Committee #07: Late Effects and Quality of Life
Dvorak, C. C.
Opportunistic Infections: Towards Risk-Adapted Prophylaxis Strategies
(PEDS) Pediatric PM Concurrent Session #2: Complications of Transplant for Non-Malignant Conditions

F

Farnia, S.
(ADMIN) What's New in Coding?
Fenske, T.
Conventional Therapy and Novel Agents for Follicular Lymphoma
Fernandez Vina, M. A.
(WC) CIBMTR Working Committee #03: Immunobiology
Filipovich, L.
Autoimmune Cytopenias Following Transplant for Non-malignant Disorders
Fisher, S.
Test
Flowers, M. E. D.
(WC) CIBMTR Working Committee #18: Graft-Versus-Host-Disease
Forman, S. J.
Gene Therapy Approaches to HIV-1 Infection in the Context of Autologous HCT
Fowler, D.
(WC) CIBMTR Working Committee #06: Graft Sources and Manipulation
Franco, T.
Adult Perspective
Frans, E. V.
(Nursing) Transplant Nursing Oral Abstracts - Session 1
Friedman, J.
(CPF) Tying Quality to Payment: How Insurers Are Affecting Our Practice
Fuchs, E.
(PHARM) Haploidentical Stem Cell Transplantation: Improvement in Outcomes, a Comparison with Umbilical Cord Blood Transplantation

G

Gale, R. C.
Building the Public Inventory of Cord Blood in a Regulated Environment
Gardner, K.
Consent Issues - Who, What, Why?
(CRP/DM) Welcome
Gea-Banacloche, J.
(WC) CIBMTR Working Committee #14: Infection and Immune Reconstitution
Germain, P.
(ADMIN) Clinical Trial Transplant Billing
Gersten, I.
Long Term Follow-up Tips
Ghavamzadeh, A.
CIBMTR Awards & Assembly Meeting
Giralt, S. A.
Meet-the-Professor Session 2: Myeloma
Goldstein, G.
(ADMIN) Clinical Trial Transplant Billing
Goldstein, S. C.
(WC) CIBMTR Working Committee #09: Donor Health and Safety
Gomez Almaguer, D.
(WC) CIBMTR Working Committee #10: International Studies
Grant, M.
(Nursing) Transplant Nursing Oral Abstracts - Session 2
Gratwohl, A.
The Macroeconomics of Hematopoietic Stem Cell Transplantation
Gregory, K.
Neutropenic Diet
Grupp, S.
Transplant for Neuroblastoma: Past Experiences and Current Concepts
(PEDS) Pediatric PM Concurrent Session #1: Neuroblastoma: Issues in Transplantation

H

Hacker, E. D.
(Nursing) Transplant Nursing Oral Abstracts - Session 2
Hari, P.
(CRP/DM) Lymphoma Reporting
Heslop, H. E.
(WC) CIBMTR Working Committee #13: Cellular Therapy
Hill, G.
IL-17 and Fibrosis in Chronic GVHD
IL-17 in Transplantation - Revisiting the Th1 Paradigm of GVHD
Oral Abstracts-Session D - Allogeneic
Ho, V. T.
(WC) CIBMTR Working Committee #05: Regimen-Related Toxicity and Supportive Care
Hogan, K.
Growth Factors Post-Transplant
Horowitz, M. M.
(BMTCTN) The BMT CTN Update and The BMT CTN Future
Horwitz, E. M.
(WC) CIBMTR Working Committee #01: Immune Deficiencies/Inborn Errors of Metabolism
Hurley, C. K.
(BMTCTN) KIR: Can Anything Be More Complex Than HLA?
(CRP/DM) KIR: Can Anything Be More Complex Than HLA?

J

Jacobsohn, D. A.
(WC) CIBMTR Working Committee #07: Late Effects and Quality of Life
Jenkins, T.
(Nursing) Transplant Nursing Oral Abstracts - Session 1
Jim, H.
Interventions to Improve Energy and Stamina
Joffe, S.
(WC) CIBMTR Working Committee #11: Health Policy and Psychosocial Issues
Jones, R. B.
Multi-Program Clinical Data Sharing - SCTOD and Beyond
SCT Electronic Data Sharing: The BRIDG SCT Database
Joseph, T. L.
Test

K

Kalaycio, M. E.
(WC) CIBMTR Working Committee #08: Chronic Leukemia
Keating, A.
(WC) CIBMTR Working Committee #13: Cellular Therapy
Kennedy, L.
Premedication for Blood Products
Khan, T.
#100 Evolution of the Pharmacy Practice Model to Improve Patient and Learner Outcomes: A Partnership in Patient Care Initiative (PIPC) in the HCT Population
Kitko, C. L.
Pulmonary Complications Following Allogeneic Transplant: Infections and Bronchiolitis Obliterans Syndrome
(PEDS) Pediatric AM Concurrent: Session #1: Sclerotic and Fibrotic Manifestations of Chronic GVHD
(WC) CIBMTR Working Committee #04: Pediatric Cancer
Knutson, D. J.
(CRP/DM) Welcome
Konsler, G. K.
Organizing a Study Folder
Koreth, J.
Emerging Agents in HCT
Oral Abstracts-Session E - GVH/GVL
BMT Tandem Luncheon Symposium: Emerging Agents in HCT
Krischer, J.
Study Design; Clinically Relevant Outcomes
Kulkarni, S.
Fun Explanation of Key Fields and Override Codes and Other Useful Tidbits

L

Lapidot, T.
Regulation of the HSC Pool in the Bone Marrow by the Coagulation System and α-Smooth Muscle Actin+ Monocytes
Laport, G. G.
When to Transplant in Follicular NHL
(CRP/DM) Lymphoma Reporting
BMT Tandem Luncheon Symposium: Indolent Lymphoma - Prognosis, Therapy and Transplant
(WC) CIBMTR Working Committee #12: Lymphoma
Larsen, H.
THE INCIDENCE OF NEW MALIGNANCY IN PATIENTS WITH ACUTE LEUKAEMIA TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Lassiter, M.
(Nursing) Welcome/Announcements
Latchford, T.
(Nursing) Transplant Nursing Oral Abstracts - Session 2
Laughlin, M. J.
(WC) CIBMTR Working Committee #06: Graft Sources and Manipulation
Lawitschka, A.
Clinical Manifestation of cGVHD in Children
Leather, H.
(PHARM) HCT in 2020 System Capacity Initiative: Progress of the Pharmacy Working Group
Lee, S. J.
Economic Outcome Measures
(CPF) Chronic GVHD - Utilizing the NIH Consensus Guidelines
Supportive Care of Transplant Patients
Leech, M.
(PHARM) Management of Hyperlipidemia in HCT
LeMaistre, C. F.
(ASBMT) Medical Directors Conference
Levine, J. E.
GVHD Biomarkers in Clinical Trials
BMT Tandem Meetings Best Abstracts
Welcome to the 2012 BMT Tandem Meetings
Biomarkers of Acute and Chronic GVHD
Lewis, J.
(PHARM) Infectious Disease Updates (ICAAC/IDSA/Year in Review)
Lonial, S.
(WC) CIBMTR Working Committee #15: Plasma Cell Disorders

M

Majhail, N. S.
Center Factors and Transplant Outcomes - Are They Related?
(BMTCTN) Long-Term Outcomes
(CRP/DM) Long-Term Outcomes
Malech, H. L.
(WC) CIBMTR Working Committee #01: Immune Deficiencies/Inborn Errors of Metabolism
Maloney, D. G.
(WC) CIBMTR Working Committee #12: Lymphoma
Marinkovich, W.
(ADMIN) Blue Distinction Centers for Transplants - A View from Across the System
Martin, P.
(ADMIN) Blue Distinction Centers for Transplants - A View from Across the System
Martin, P. J.
(ASBMT) E. Donnall Thomas Lecture
Matlack, M.
Process Review: How Can it Help Me in My Job?
(CRP/DM) CIBMTR Hot Topics
Matsui, W. H.
Targeting Myeloma Stem Cell Self-Renewal
BMT Tandem Breakfast Symposium: Myeloma Cancer Stem Cells
Maziarz, R. T.
(PHARM) Expanding Applications of Cellular Therapy for Indications Other Than Malignancy
(WC) CIBMTR Working Committee #08: Chronic Leukemia
McCarthy, P. L.
(WC) CIBMTR Working Committee #05: Regimen-Related Toxicity and Supportive Care
McCune, J.
(CPF) Drug Metabolism in Stem Cell Transplant
Mehta, P. A.
Hematopoietic Cell Transplantation for Chromosome Sensitivity Syndromes
Oral Abstracts-Session H - Pediatric
Meiers, S.
(CRP/DM) Welcome
Meshinchi, S.
Biomarkers for Risk Identification in AML
(PEDS) Pediatric BMT Program - Transplantation for AML in Children: Challenges for the Coming Decade
Miklos, D. B.
(WC) CIBMTR Working Committee #03: Immunobiology
Miller, J. S.
Clinical Trials to Exploit NK Cells in Cancer and Transplantation
NK Cells - From Bench to Clinic
Miller, J. P.
The NMDP IND Experience: From a Registry and Network Perspective
Milone, G. A.
(WC) CIBMTR Working Committee #15: Plasma Cell Disorders
Minas, N. M.
CIBMTR MONTHLY INTERNAL ASSESSMENT IMPROVES QUALITY OF REGISTRY DATA
Mitsiades, C. S.
The Impact of Lenalidomide on Myeloma Cells with Stem Cell-Like Features
Montoto, S.
(WC) CIBMTR Working Committee #12: Lymphoma
Mueller, C. R.
(WC) CIBMTR Working Committee #03: Immunobiology
Muraro, P. A.
Immunological Foundation of Autologous HCT for Autoimmune Disease
(WC) CIBMTR Working Committee #17: Autoimmune Diseases
Murphy, W.
NK Cell Subsets in Viral Infection and Cancer Using Mouse Models

N

Navarro, W. H.
(BMTCTN) Viral Infections
(CRP/DM) Viral Infections
Nemecek, E. R.
Oral Abstracts-Session C - Pediatric
Neumann, J.
(Nursing) Transplant Nursing Oral Abstracts - Session 2
(Nursing) Moral/Ethical Issues
Niederwieser, D.
The Worldwide Network for Blood and Marrow Transplantation - An Update
WBMT

O

O'Donnell, P. V.
2:15PM-2:45PM BMT CTN 1101 Double Cord vs Haplo
(WC) CIBMTR Working Committee #09: Donor Health and Safety
O'Neill, C.
(CRP/DM) FormsNet/AGNIS
O'Shea, J. J.
IL-17, An Overview
Osagie, N.
#101 Correlation of Medication Burden and Quality of Life in Allogeneic Hematopoietic Stem Cell Transplant Patients
Oswald, C.
Tried and True Ways to Get Information from Referring Physicians

P

Paczesny, S.
Biomarkers in Acute GVHD
Parham, P.
Immunogenetic Modulation of NK Cell Biology
Parran, L.
(ADMIN) Benchmarking - If the Shoe Fits?
Parsons, S. K.
(WC) CIBMTR Working Committee #11: Health Policy and Psychosocial Issues
Pasquini, M. C.
0702 - Advantage EDC Changes Overview and 0702 MST Form
(BMTCTN) Cellular Therapy for Regenerative Medicine (& More)
(BMTCTN) BMT CTN Open Protocols
(CRP/DM) Cellular Therapy for Regenerative Medicine (& More)
Patel, L.
The Ins and Outs of Outpatient Transplant: A Pediatric and Adult Perspective
Patnaik, M.
(APP) Advanced Practice Professionals - Hematologic Complications Post-Transplant
Pavletic, S. Z.
BMT Tandem Breakfast Symposium: Autologous HCT for Autoimmune Disease - is it Now Ready for Prime Time?
(WC) CIBMTR Working Committee #17: Autoimmune Diseases
Petcoff, M.
(CRP/DM) CIBMTR Audits
Peters, C.
Extracorporeal Photopheresis
(PEDS) International Session: Non-Pharmaceutical Treatment of Chronic GVHD in Children - the European Experience
Pulsipher, M. A.
(APP) Allogeneic Transplantation for Pediatric ALL: Indications, Approaches and Outcomes

R

Rao, K. V.
Outpatient Stem Cell Transplant Clinic (Rao)
(PHARM) Best Practices: Outpatient Stem Cell Transplant Clinic
Reddy, P.
Biology of GVHD: Evolving Paradigms
Clinical Utility of HDAC Inhibitors Post-HSCT
Repaczki-Jones, R.
(ADMIN) New FACT Cellular Therapy Standards and the Transition to Online Accreditation
Rimkus, C.
(Nursing) Welcome/Announcements
Rizzieri, D.
(PHARM) Role of HCT in Flt-3+ AML
Rizzo, J. D.
Update: 2011 Late Effects Monitoring Recommendations
SCTOD Update
(CRP/DM) CIBMTR Update
(CRP/DM) Cause of Death
Rocha, V.
A Global View of Cord Blood Transplantation

S

Sanacore, M.
#102 Effect of Cytoxan Dosing on Hematopoietic Stem Cell (HSC) Mobilization Efficacy, Toxicity, and Cost in Successive Cohorts of Non-Hodgkin's Lymphoma (NHL) Patients
Sarantopoulos, S.
BAFF and B-Cell Subsets in Chronic GVHD: Biologically Relevant Markers for Future Studies
Schmit-Pokorny, K.
(Nursing) Day 2 - Announcements/SIG Update
Seber, A.
Oral Abstracts-Session F - Supportive Care
(WC) CIBMTR Working Committee #04: Pediatric Cancer
Sehn, L. H.
Prognostic Factors in Follicular non-Hodgkin Lymphoma
Serody, J. S.
Th17/Th22 Cells and Acute GVHD: Lead Actors or Bit Players?
Shapiro, J.
(PHARM) Graft Versus Host Disease: Advances in the Past 12 Months
Sharf, S. E.
(Nursing) Transplant Nursing Oral Abstracts - Session 1
Shea, T. C.
Oral Abstracts-Session G - Allogeneic
Shelton, B.
(Nursing) Oncologic Emergencies
Shenoy, S.
(WC) CIBMTR Working Committee #19: Non-Malignant Marrow Disorders
Shinkle, M.
#103 Once Daily Dose (ODD) Lorazepam (Lo) for Seizure Prophylaxis in Conjunction with Once Daily Dose Busulfan (BU) for Pediatiric Patients Undergoing Reduced Intensity Conditioning (RIC) for Allogeneic Stem Cell Transplantation (HCT)
Shinkle, M.
(ADMIN) Cost Savings Measures through Collaboration
Shpall, E. J.
(ASBMT) Regulatory Affairs Conference
Oral Abstracts-Session I - Clinical Cellular Therapy
Shurin, S. B.
Clinical Trials In BMT: Ensuring that rare diseases and rarer therapies are well done
NHLBI Welcome Address
Clinical Trials
Sirilla, J.
(ADMIN) DAY 2 Welcome and Introductions
(ADMIN) BMT Center Administrators Welcome and Introductions
Smith, J.
(CRP/DM) FormsNet/AGNIS
Socié, G.
GVHD: Translating Mice to Humans
Magnitude of Risk and Association with Demographic and Therapeutic Factors
Soiffer, R. J.
The Case Against ATG
Sorror, M. L.
(WC) CIBMTR Working Committee #07: Late Effects and Quality of Life
Stadtmauer, E. A.
(WC) CIBMTR Working Committee #02: Solid Tumors
Steinert, P.
KGF - A Prospective Study Approach
Stolar, K.
(Nursing) Survivorship Post Transplant
Stroncek, D. F.
(WC) CIBMTR Working Committee #09: Donor Health and Safety
Syrjala, K. L.
Interventions to Improve Chemo-Brain and Emotional Distress
Szabolcs, P.
Tolerance After Blood and Marrow Transplantation
Umbilical Cord Blood Transplantation Following Reduced Intensity Conditioning for Non-Malignant Disorders
Tolerance
(WC) CIBMTR Working Committee #14: Infection and Immune Reconstitution
Szydlo, R. M.
(CRP/DM) Abstracts and Posters for Live Presentation

T

Talano, J. A.
Strategies for the Prevention of Relapse in Pediatric Patients with Myeloid Malignancy Undergoing Allogeneic HCT
Taniguchi, S.
The Fukushima Nuclear Accident - The Transplant Team Experience
Tate, C.
(PHARM) How I Treat Viral Cystitis
Thole, T.
How to Train a Brand New Data Manager - What They Really Need to Know
Thomas, T.
Tried and True Ways to Get Information from Referring Physicians
Thompson, J.
Lab Compliance
(BMTCTN) BMT CTN - Navigating the BMT CTN Private and Public Website
Thomson, A. W.
Tolerogenic Antigen Presenting Cells in Particular Dendritic Cells Primarily in the Context of Liver Transplantation
Tierney, D. K.
(Nursing) Day 2 - Announcements/SIG Update
Tolar, J.
HCT for Epidermolysis Bullosa
Tomblyn, M. R.
(APP) Aggressive Lymphomas
(CPF) CIBMTR - AE Toxicity Grading

U

Ueno, N. T.
(WC) CIBMTR Working Committee #02: Solid Tumors
Urbano-Ispizua, A.
(WC) CIBMTR Working Committee #18: Graft-Versus-Host-Disease

V

van Laar, J.
Transplantation for Systemic Sclerosis and ASTIS Trial
Verneris, M. R.
NK Cell Immuno-therapy and Engraftment in Treating for High Risk Malignancies
(PEDS) Pediatric AM Concurrent Sessions #2: Methods to Overcome Engraftment Barriers in Pediatric Transplantation
Vose, J. M.
3:00PM-3:15PM BMT CTN 0401 BEAM-Bexxar Lymphoma
(PHARM) Role of HCT in Mantle Cell Lymphoma

W

Wagers, A.
Hematopoietic Stem Cells and Aging
Waldoch, D.
Test
Wallace, P.
What Does It Really Mean to be a "Primary Data Contact"
Walsh-Chocolaad, T.
(PHARM) 2011 ASH Meeting Updates
Walston, J.
Biomarkers, Frailty and Aging: Can Transplant Physicians Borrow from the Geriatric Toolbox?
Walters, M.
HCT for Hemoglobin Disorders
HCT for Non-Malignant Disorders
Warkentin, P. I.
(ADMIN) New FACT Cellular Therapy Standards and the Transition to Online Accreditation
Warren, E. H.
Applications of Sequencing for Immune Monitoring and Detecting Disease Relapse
Wayne, S.
How to Complete Those Lovely Error Correction and Lost to Follow-Up Forms
Weaver, C.
Accurate Data Reporting
Preparing for an Audit
Weisdorf, D. J.
BMT Tandem Luncheon Symposium: GVHD Prevention: An Ounce Is Better Than A Pound
White, E.
Lessons Learned from Other Disciplines: Laboratory Insights into Pulmonary Fibrosis
Tissue Fibrosis: Too Much of a Good Thing?
Wilhelm, K. L.
Outpatient Stem Cell Transplant Clinic (Wilhelm)
Putting the Evidence into Practice: Optimized Dosing and Administration of Reduced-Intensity Conditioning Regimens
Putting the Evidence into Practice: Optimized Dosing and Administration of Reduced-Intensity Conditioning Regimens
Putting the Evidence into Practice: Optimized Dosing and Administration of Reduced-Intensity Conditioning Regimens
Wonnacott, K.
FDA Update On Regulation of Cord Blood
Wu, C.
Whole Tumor Sequencing for Discovering GVL/GVHD Targets
Applications of Next-Generation Sequencing
Oral Abstracts-Session A - Allogeneic Transplantation

Y

Yanik, G.
Role of MIBG Therapy for High Risk Neuroblastoma
Meet-the-Professor Session 3: Pediatric Neuroblastoma

Z

Zon, L. I.
Pathways Regulating Stem Cell Self-Renewal and Engraftment
Hematopoietic Stem Cell Biology

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z